Search results
Results from the WOW.Com Content Network
Dana–Farber Cancer Institute (DFCI) is a comprehensive cancer treatment and research center in Boston, Massachusetts.Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.
The Dana-Farber/Boston Children's Cancer and Blood Disorders Center is a well-known hospital in Boston, Massachusetts, focused on treating children with cancer and blood disorders. [53] It brings together the resources and expertise of Dana-Farber Cancer Institute and Boston Children's Hospital to offer advanced care and innovative treatments ...
The East Campus retained most primary care, outpatient, clinical and administrative functions, while the emergency department, inpatient care, the department of human resources, and many specialists are located on the West Campus. The medical center has more than 6,000 full-time employees. [25]
Dana–Farber Cancer Institute; Whitehead Institute for Biomedical Research (Massachusetts Institute of Technology) Missouri. McDonnell Genome Institute (Washington University in St. Louis) New Mexico. National Center for Genome Resources; New York. Cold Spring Harbor Laboratory; Icahn Institute for Genomics and Multiscale Biology (Icahn School ...
Broad Institute of MIT and Harvard, Cambridge, Massachusetts. The Eli and Edythe L. Broad Institute of MIT and Harvard (IPA: / b r oʊ d /, pronunciation respelling: BROHD), [1] often referred to as the Broad Institute, is a biomedical and genomic research center located in Cambridge, Massachusetts, United States.
Comprehensive cancer centers may apply for up to $1.5 million per year from the Department of Health and Human Services. [ 2 ] Clinical Cancer Centers generally conduct a combination of basic, population sciences, and clinical research, and are encouraged to stimulate collaborative research involving more than one field of study.
In 1947, Sidney Farber founded the Dana-Farber Cancer Institute in Boston.The following year he launched the Jimmy Fund to raise money to support the hospital. [9] [10] The fund was named after a patient who was named "Jimmy" to protect his identity – his real name was Einar Gustafson and his identity was revealed in 1998.
Benjamin Levine Ebert, MD, PhD, is the president and CEO of Dana–Farber Cancer Institute, the Richard and Susan Smith Professor of Medicine at Harvard Medical School and director of the Dana-Farber/Harvard Cancer Center. Ebert succeeded Laurie Glimcher as president and CEO in October 2024. [1]